|Assessment Status||Rapid Review complete|
|Brand||CoQun® eye drops|
|Indication||As a complementary add-on treatment to antihypertensive glaucoma therapy.|
|Rapid review commissioned||16/10/2019|
|Rapid review completed||13/01/2020|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that CoQ10 eye drops not be considered for reimbursement*.|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.